Cochrane Gynaecology and Fertility (CGF) 2018 Highlights

 Cochrane Gynaecology and Fertility Group Implements a New Peer Review Policy 

The results from an updated Cochrane review show that live birth rate and clinical pregnancy rate are probably increased in women having day 3 embryo transfer (ET) with a pregnancy hormone dose of 500 IU or higher compared to women having day 3 ET without pregnancy hormone.

18 October is World Menopause Day and October is World Menopause Month. Cochrane Gynaecology and Fertility Group has published multiple reviews assessing the effectiveness and safety of interventions in menopausal women, including peri and postmenopausal women. To celebrate World Menopause Day we have collated a special selection of reviews investigating various treatments for menopausal symptoms such as hormone therapy, tibolone, relaxation, exercise, and alternative therapy. 

See below some useful links and key highlights!

The Colloquium is a multi-disciplinary event exchanging ideas about how we best generate, summarize and communicate evidence to inform and change practice and policy worldwide. Schedule and sign-up The full schedule of talks, workshops and special sessions can be found here. 

The recently published updated review on Aromatase inhibitors for subfertility treatment in women with polycystic ovary syndrome (PCOS) has been featured in the Cochrane Podcast series.

Registration has now opened for the 25th annual Cochrane Colloquium. Register before 15 June 2018 to get the reduced early bird rate!

The 34th Annual Meeting of ESHRE will be held in Barcelona, Spain, from 1 to 4 July 2018. Register before 2 May 2018 with a reduced early bird registration fee.For more information go to:  https://www.eshre.eu/Barcelona2018. 

Cochrane Gynaecology and Fertility Group in Auckland, New Zealand in collaboration with the Academic Medical Center of the University of Amsterdam, has established a new Cochrane Gynaecology and Fertility satellite.